Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
Therapeutic Structure Inc
Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…
Structure Therapeutics CEO talks obesity pill and more
Ray Stevens, CEO of Structure Therapeutics Inc., during a Bloomberg Television interview at the JPMorgan Healthcare Conference in San Francisco,…
Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…